Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

50 projects found matching your search criteria :

  1. Estrogen receptor GPER as a modulator of inflammatory and functional gastrointestinal diseases and colorectal cancer

    Call: PRELUDIUM 9 , Panel: NZ5

    Principal investigator: Damian Jacenik

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

  2. Maturation, pharmacogenomics, and metabolomics as factors determining pharmacokinetic and pharmacodynamics profile of al...

    Call: OPUS 9 , Panel: NZ7

    Principal investigator: dr hab. Paweł Wiczling

    Gdański Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  3. COX-2 inhibitors and/or PPAR agonists-conjugated PAMAM G3 dendrimers targeted into cancer cells. Biological properties a...

    Call: SONATA 7 , Panel: NZ3

    Principal investigator: dr Łukasz Uram

    Politechnika Rzeszowska im. Ignacego Łukasiewicza, Wydział Chemiczny

  4. Searching for alternative derivatizing agents for the trace analysis of pharmaceuticals in natural samples using gas chr...

    Call: PRELUDIUM 1 , Panel: ST4

    Principal investigator: dr Magda Caban

    UNIWERSYTET GDAŃSKI

  5. Molecular mechanisms of activation and modulation of recombinant GABAA receptors by selected agonists and modulators

    Call: OPUS 6 , Panel: NZ3

    Principal investigator: prof. Jerzy Mozrzymas

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski

  6. Influence of antagonists (scopolamine and 3-quinuclidinyl benzilate) and agosists (carbachol) of muscarinic cholinergic ...

    Call: PRELUDIUM 5 , Panel: NZ9

    Principal investigator: Szymon Chowański

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  7. Functions and costs ensuring signal reliability of so-called soft song in agonistic interactions in birds

    Call: OPUS 5 , Panel: NZ8

    Principal investigator: prof. Tomasz Osiejuk

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

  8. The influence of glucagon-like peptied-1 receptor agaonists on regulation of coticotropin-releasing hormone gene promote...

    Call: PRELUDIUM 4 , Panel: NZ7

    Principal investigator: Jan Detka

    Instytut Farmakologii PAN

  9. Structural studies based on low sequence similarity of G protein-coupled receptors activated by hormones and allosteric ...

    Call: SONATA 4 , Panel: NZ1

    Principal investigator: dr Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

  10. The influence of some selected antiepileptic drugs in combination with arachinodyl-2-chlorethylamide, a selective cannab...

    Call: OPUS 3 , Panel: NZ7

    Principal investigator: dr Marta Andres-Mach

    Instytut Medycyny Wsi im. Witolda Chodźki

  11. Influence of PPAR-gama receptor agonists on antitumor activity of photodynamic therapy.

    Call: PRELUDIUM 3 , Panel: NZ5

    Principal investigator: dr Piotr Mrówka

    Warszawski Uniwersytet Medyczny, Wydział Nauki o Zdrowiu

  12. Structure-activity relationship of bifunctional peptides, agonists of opioid receptors and antagonists of neurokinin rec...

    Call: PRELUDIUM 2 , Panel: ST5

    Principal investigator: Jolanta Dyniewicz

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  13. Conjugated linoleic acid (CLA)-induced transcriptional activation of PPAR-an investigation of molecular machanisms of pu...

    Call: OPUS 2 , Panel: NZ9

    Principal investigator: prof. Teresa Leszczyńska

    Uniwersytet Rolniczy im. Hugona Kołłątaja w Krakowie, Wydział Technologii Żywności

  14. Partial agonists alpha1A/D-adrenoceptors as potential compounds that improve urodynamic parameters in benign prostatic h...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr hab. Jacek Sapa

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  15. Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Agnieszka Wnuk

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  16. Retro-inverso modification of zinc(II)–GLP-1 receptor agonist complexes – from bioinorganic chemistry to animal studies...

    Call: OPUS 26 , Panel: ST5

    Principal investigator: dr hab. Magdalena Rowińska-Żyrek

    Uniwersytet Wrocławski, Wydział Chemii

  17. Argument Mining: Public Debate Models and Algorithmically-Assisted Argument Extraction

    Call: OPUS 25 , Panel: HS5

    Principal investigator: dr Rafał Olszowski

    Akademia Górniczo-Hutnicza im. Stanisława Staszica w Krakowie, Wydział Humanistyczny

  18. Quiet threat or lure? Determining the function of low-amplitude signals used by birds during agonistic interactions

    Call: SONATA 18 , Panel: NZ8

    Principal investigator: dr Krzysztof Deoniziak

    Uniwersytet w Białymstoku

  19. Searching for natural bioactive farnesoid X receptor agonists and their role in parenteral nutrition-associated liver di...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr hab. Maciej Stawny

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  20. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

    Call: OPUS 23 , Panel: NZ7

    Principal investigator: dr Katarzyna Szczepańska

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  21. Partial agonists of alpha-2 adrenoceptors as new perspective of the effective and safe in reducting body weight and obes...

    Call: OPUS 2 , Panel: NZ7

    Principal investigator: dr Magdalena Dudek

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  22. The effect of chronic administration of purine P1-A2B receptor agonist, using electrospun microfibers, on intrarenal blo...

    Call: PRELUDIUM 21 , Panel: NZ5

    Principal investigator: Joanna Sitek

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  23. Dual 5-HT3 receptor/5-HT6 receptor antagonists in neuropsychiatric and neurological disorders

    Call: OPUS 22 , Panel: NZ7

    Principal investigator: prof. Paweł Zajdel

    Uniwersytet Jagielloński, Collegium Medicum

  24. New approach to the treatment of Alzheimer's disease targetingresolution of inflammation and modulation of biomechanical...

    Call: OPUS 22 , Panel: NZ4

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  25. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search...

    Call: OPUS 21 , Panel: NZ7

    Principal investigator: prof. Marcin Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

  26. Self-learning systems in the design of compounds modulating GPCR receptors activation.

    Call: OPUS 20 , Panel: NZ2

    Principal investigator: dr hab. Dorota Latek

    Uniwersytet Warszawski, Wydział Chemii

  27. The significance of circadian rhythm in urinary bladder cancer: deregulation of circadian genes as a putative therapeuti...

    Call: OPUS 19 , Panel: NZ5

    Principal investigator: prof. Edyta Reszka

    Instytut Medycyny Pracy im. prof. dr. med. Jerzego Nofera

  28. Molecular mechanism underlying the anti-inflammatory action of CB2 receptor agonists in microglia: participation of the ...

    Call: OPUS 19 , Panel: NZ7

    Principal investigator: dr Natalia Małek-Chudzik

    Politechnika Wrocławska

  29. Investigation of novel functionally selective opioid receptors agonists

    Call: ETIUDA 8 , Panel: NZ7

    Principal investigator: Łucja Kudła

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  30. Investigation of molecular mechanisms of rapid antidepressant action of NLX-101, a biased agonist of the 5-HT1A receptor...

    Call: OPUS 18 , Panel: NZ7

    Principal investigator: prof. Mariusz Papp

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  31. In vivo effects, underlying signaling pathways and mechanism of action of ghrelin receptor agonist against pathological ...

    Call: SONATA 15 , Panel: NZ7

    Principal investigator: dr Piotr Chmielarz

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  32. Quantitative assessment of vascular endothelial growth factor (VEGF) in serum, follicular fluid (FF) and VEGF mRNA in gr...

    Call: OPUS 1 , Panel: NZ5

    Principal investigator: prof. Artur Jakimiuk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  33. Searching for the background underlying the neuroprotective effects of the specific agonist of Y2 receptors - NPY(13-36)...

    Call: PRELUDIUM 17 , Panel: NZ4

    Principal investigator: Łukasz Przykaza

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  34. Application of machine learning based artificial intelligence to search for substances that modulate the activity of ROR...

    Call: OPUS 17 , Panel: NZ7

    Principal investigator: dr hab. Marcin Ratajewski

    Instytut Biologii Medycznej Polskiej Akademii Nauk

  35. Połączone działanie agonistów receptorów adenozynowych i antagonistów receptora P2Y12 zwiększa hamowanie funkcji płytek ...

    Call: ETIUDA 7 , Panel: NZ3

    Principal investigator: Nina Wolska

    Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu

  36. Rational design and evaluation of functionally biased opioid agonists

    Call: OPUS 16 , Panel: NZ7

    Principal investigator: prof. Ryszard Przewłocki

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  37. Searching for mu opioid receptor peptide agonists with G protein/beta-arrestin biased profile and their pharmacological ...

    Call: SONATA 14 , Panel: ST5

    Principal investigator: dr Justyna Piekielna-Ciesielska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  38. Molecular mechanism of anticancer action of selected NSAIDs as a PPAR gamma receptor agonists in experimental models of ...

    Call: PRELUDIUM 14 , Panel: NZ7

    Principal investigator: Adam Kazberuk

    Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

  39. Modulation of inflammatory processes using new agonists of the formyl peptide receptors ALX/FPR2 as a new therapeutic st...

    Call: HARMONIA 9 , Panel: NZ7

    Principal investigator: prof. Agnieszka Basta-Kaim

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  40. Development of unique molecular probes: low-basicity agonists for the study of 5-HT7 receptor function

    Call: OPUS 13 , Panel: NZ7

    Principal investigator: prof. Andrzej Bojarski

    Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

  41. Concepts of Agonistic Democracy

    Call: PRELUDIUM 1 , Panel: HS5

    Principal investigator: Filip Biały

    Uniwersytet im. Adama Mickiewicza, Wydział Nauk Politycznych i Dziennikarstwa

  42. Investigation of the mechanisms of the neuroprotective effect of group II metabotropic receptors (mGluR2/3) agonist in a...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: dr Ewelina Bratek

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego Polskiej Akademii Nauk

  43. Piperazine derivatives as active histamine H3 receptor ligands - molecular modeling, synthesis, pharmacological evaluati...

    Call: PRELUDIUM 12 , Panel: NZ7

    Principal investigator: Katarzyna Szczepańska

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  44. Molecular receptors as a tool for studies of interactions agonist/antagonist of H1 - H4 receptors

    Call: PRELUDIUM 11 , Panel: ST5

    Principal investigator: Małgorzata Walczak

    Politechnika Łódzka, Wydział Chemiczny

  45. Biased inverse agonists of 5-HT6 receptor and dual 5-HT6/MAO-B inhibitors - in search for new therapeutic approaches for...

    Call: OPUS 11 , Panel: NZ7

    Principal investigator: prof. Paweł Zajdel

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  46. Phosphorylation of the A/B domain as the crucial mechanism involved in substrate specificity of the two isoforms (RORgam...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: dr Marcin Ratajewski

    Instytut Biologii Medycznej Polskiej Akademii Nauk

  47. Search for the functionally selective 5-HT1A receptor agonists as new pharmacological tools in the development of treatm...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: prof. Marcin Kołaczkowski

    Uniwersytet Jagielloński - Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  48. 5-HT6 receptor ligands as addition to antipsychotic therapy in schizophrenia - an impact on body weight, metabolic param...

    Call: OPUS 10 , Panel: NZ7

    Principal investigator: prof. Anna Wesołowska

    Uniwersytet Jagielloński Collegium Medicum, Collegium Medicum, Wydział Farmaceutyczny

  49. Metabolic profiling of HIF stabilizers, PPAR agonists and SARMs by means of UPLC-MS/MS.

    Call: PRELUDIUM 9 , Panel: ST4

    Principal investigator: Katarzyna Kowalczyk

    Uniwersytet Warszawski, Wydział Chemii

  50. Development of a method for the structure prediction of GPCRs complexes with agonists and antagonists, including the lig...

    Call: SONATA 1 , Panel: NZ2

    Principal investigator: dr Michał Koliński

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN